MAP2K7 and Hypoalbuminemia: Furthermore, given the notable poor outcome of ICI treatment in patients with hypoalbuminemia plus elevated LDH levels, prospective follow-up studies are needed to investigate whether these patients would benefit from prioritizing other treatment modalities over ICI treatment, e.g. BRAF/MEK-targeting agents.